- COMMENT
When will clinical trials finally reflect diversity?
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 557, 157-159 (2018)
doi: https://doi.org/10.1038/d41586-018-05049-5
References
Ramamoorthy, A., Pacanowski, M. A., Bull, J. & Zhang, L. Clin. Pharmacol. Ther. 97, 263–273 (2015).
Mullard, A. Nature Rev. Drug Discov. 14, 77–81 (2015).
United Nations Population and Vital Statistics Report (United Nations, 2014); available at go.nature.com/2HUz7JA
Wang, Y. et al. J. Am. Med. Assoc. 316, 70–78 (2016).
Shu, Y. & Zhou, H. H. Acta Pharmacol. Sin. 21, 193–199 (2000).
Scott, S. A. et al. Clin Pharmacol. Ther. 94, 317–323 (2013).
McLeod, H. L., Krynetski, E. Y., Relling, M. V. & Evans, W. E. Leukemia 14, 567–572 (2000).
Moriyama, T. et al. Nature Genet. 48, 367–373 (2016).
Knepper, T. C. & McLeod, H. L. J. Clin. Oncol. 33, 1230–1231 (2015).
Shirotani, M., Suwa, T., Kurokawa, T. & Chiba, K. J. Clin. Pharmacol. 54, 438–445 (2014).
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. General Principles For Planning And Design Of Multi-Regional Clinical Trials E17 (ICH, 2017); available at go.nature.com/2jik8bz